ARCHIVES

FEBT, For Pain Control, Shows Positive Results In Phase III

This article is from The Cancer Letter archive.

Vol. 29 No. 5 | May 26, 2006

Download PDF Visit The Full Archive

Related Articles

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

Regulatory Agencies: HCFA Proposes Physician Transfer Of Drug Discounts To Medicare, Insurers

April 3, 1998

Cancer Letter Adds Associate Editor

July 19, 1985

Reader Finds Letter insulting to Ethic Group

February 16, 1996

NCAB Gives President Evidence Supporting Limits On Tar, Nicotine

November 29, 1974

Bill Would Harm Pancreatic Cancer Research – Scientists Warn Of Unintended Consequences

August 10, 2012